High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency

Bone Marrow Transplantation

Volumn 20, Issue 8, 1997, Pages 653-656

  Ballester, O F ^a   Tummala, R ^a   Janssen, W E ^a   Fields, K K ^a   Hiemenz, J W ^a   Goldstein, S C ^a   Perkins, J B ^a   Sullivan, D M ^a   Rosen, R ^a   Sackstein, R ^a   Zorsky, P ^a   Saez, R ^a   Elfenbein, G J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Autologous stem cell transplantation; High dose therapy; Myeloma; Renal failure

Indexed keywords

BUSULFAN; CREATININE; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBDURAL HEMATOMA;

EID: 0030681016     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700950     Document Type: Article

References (24)

1. Barlogie B, Epstein J, Selvanayagam P, Alexanian R. Plasma cell myeloma - new insights and advances in therapy. Blood 1989; 73: 865-879.
2. Boccadoro M, Pileri A. Standard chemotherapy for myelomatosis: an area of great controversy. Hematol Oncol Clin N Am 1992; 6: 371-382.
3. Gregory WE, Richards MA, Malpas JS. Combination chemotherapy vs melphalan and prednisone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol 1992; 10: 334-342.
4. Vesole DH, Tricot G, Jagannath S et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996; 88: 838-847.
5. Cunningham D, Paz-Ares L, Milan S et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 1994; 12: 759-763.
6. Attal M, Harousseau JL, Stoppa AM et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91-97.
7. Kyle RA, Bayrd ED. The monoclonal gammopathies: multiple myeloma and related disorders. Charles Thomas: Springfield, Illinois, 1975, pp 91-94.
8. MacLennan ICM, Cooper EH, Chapman CE el al. Renal failure in myelomatosis. Eur J Haematol 1994; 43 (Suppl. 51): 60-65.
9. Alexanian R, Barlogie B, Dixon D. Renal failure in multiple myeloma: pathogenesis and prognostic implications. Arch Intern Med 1990; 150: 1693-1695.
10. Ballester OF, Agaliotis DP, Hiemenz JW et al. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery. Bone Marrow Transplant 1996; 18: 9-14.
11. Knudsen LM, Hippe E, Hjorth M et al. Renal function in newly diagnosed multiple myeloma - a demographic study of 1353 patients. Eur J Haematol 1994; 53: 207-212.
12. Johnson WJ, Kyle RA, Pinda AA et al. Treatment of renal failure associated with multiple myeloma: plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990; 150: 863-869.
13. Torra R, Blade J, Cases A et al. Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases. Br J Haematol 1995; 91: 854-859.
14. Wahlin A, Lofvenberg E, Holm J. Improved survival in multiple myeloma with renal failure. Acta Med Scand 1987; 221: 205-209.
15. Misiani R, Tiraboschi G, Mingardi G, Mecca G. Management of myeloma kidney: an anti-light-chain approach. Am J Kid Dis 1987; 10: 28-33.
16. Rota S, Mougenot B, Baudouin B et al. Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients. Medicine 1987; 66: 126-137.
17. lggo N, Palmer ABD, Severn A et al. Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment. Q J Med 1989; 270: 903-910.
18. Korzets A, Tam F, Russell G et al. The role of continuous peritoneal dialysis in end stage renal failure due to multiple-myeloma. Am J Kid Dis 1990; 26: 216-223.
19. Innes A, Cuthbert RJG, Russell NH et al. Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol 1994; 16: 149-156.
20. Jagannath S, Barlogie B, Vesole D et al. Autotransplants can be performed safely in multiple myeloma patients with renal insufficiency. Blood 1995; 86 (Suppl. 1): 205a.
21. Arbuck SG, Douglass HO, Crom WR. Etoposide pharmacokinetics in patients with normal and abnormal organ function. J Clin Oncol 1986; 4: 1690-1695.
22. Grochow LB, Colvin M. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 1983; 4: 380-394.
23. Talalla A, Halbrook H, Barbour BH, Krzr T. Subdural hematoma associated with long-term hemodialysis for chronic renal disease. JAMA 1970; 212: 1847-1849.
24. Inzelberg R, Neufeld MY, Reider I, Gari P. Non-surgical treatment of subdural hematoma in a hemodialysis patient. Clin Neurol Neurosurg 1989; 91: 85-89.